An uncommon cause of anaemia: Sheehan’s syndrome.

Melchardt T, Namberger K, Weiss L, Egle A, Faber V, Greil R. Wien Klin Wochenschr. 2010 Dec,122(23-24):717-9. doi: 10.1007/s00508-010-1480-4. Epub 2010 Dec 7.

MicroRNAs as biomarkers for the diagnosis and prognosis of human cancer.

Asslaber D, Pinon Hofbauer J, Greil R, Egle A. Journal of Nucleic Acids Investigations. 2010, Dec 1, 1(1): 76-80.

Inhibition of GLI, but not Smoothened induces apoptosis in chronic lymphocytic leukemia cells.

Desch P, Asslaber D, Kern D, Schnidar H, Mangelberger D, Alinger B, Stoecher M, Hofbauer SW, Neureiter D, Tinhofer I, Aberger F, Hartmann TN, Greil R. Oncogene. 2010 Sep 2,29(35):4885-95. doi: 10.1038/onc.2010.243. Epub 2010 Jul 5.

Modifying akt signaling in B-cell chronic lymphocytic leukemia cells.

Hofbauer SW, Piñón JD, Brachtl G, Haginger L, Wang W, Jöhrer K, Tinhofer I, Hartmann TN, Greil R. Cancer Res. 2010 Sep 15,70(18):7336-44. doi: 10.1158/0008-5472.CAN-09-4411. Epub 2010 Sep 7.

The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients.

Perkhofer S, Lass-Flörl C, Hell M, Russ G, Krause R, Hönigl M, Geltner C, Auberger J, Gastl G, Mitterbauer M, Willinger B, Knöbl P, Resch G, Waldner R, Makrai A, Hartmann G, Girschikofsky M, Greil R. Int J Antimicrob Agents. 2010 Dec,36(6):531-6. doi: 10.1016/j.ijantimicag.2010.08.010. Epub 2010 Oct 13.

Final Results of ABCSG-24, a Randomized Phase III Study Comparing Epirubicin, Docetaxel, and Capecitabine (EDC) to Epirubicin and Docetaxel (ED) as Neoadjuvant Treatment for Early Breast Cancer and Comparing ED/EDC plus Trastuzumab (T) to ED/EDC as Neoadjuvant Treatment for Early HER-2 Positive Breast Cancer

Steger, GG, Greil, R, Jakesz, R, Lang, A, Mlineritsch, B, Melbinger-Zeinitzer, E, Marth, C, Samonigg, H, Kubista, E, Gnant, M CANCER RES. 2009, 69(24): 564S-564S.

Neoadjuvant chemoradiation therapy with capecitabine (X) plus cetuximab (C), and external beam radiotherapy (RT) in locally advanced rectal cancer (LARC): ABCSG trial R03

Eisterer, WM, De Vries, A, Oefner, D, Greil, R, Rabl, H, Tschmelitsch, J, Schmid, R, Kapp, K, Zehentmayr, F, Thaler, J J CLIN ONCOL. 2009, 27(15):

ADDITION OF ZOLEDRONIC ACID (ZOL) TO ADJUVANT ENDOCRINE THERAPY IMPROVES DISEASE-FREE (DFS) AND RECURRENCE-FREE SURVIVAL (RFS) IN PREMENOPAUSAL WOMEN WITH HORMONE-RESPONSIVE EARLY BREAST CANCER (HREBC): MULTIVARIATE ANALYSES OF THE AUSTRIAN BREAST AND COLORECTAL CANCER STUDY GROUP 12 (ABCSG-12) TRIAL

Gnant, M, Mlineritsch, B, Schippinger, W, Luschin-Ebengreuth, G, Poestlberger, S, Menzel, C, Jakesz, R, Kubista, E, Marth, C, Greil, R ANN ONCOL. 2009, 20: 30-30.

The role of the VLA-4 integrin in adhesion and survival of chronic lymphocytic leukemia (CLL) cells

Sahakyan, K, Hofbauer, S, Brachtl, G, Girbl, T, Henschler, R, Greil, R, Hartmann, TN ONKOLOGIE. 2010, 33: 201-201.

VLA-4 and CD38 in chronic lymphocytic leukemia – more than prognostic markers?

Brechtl, G, Denk, U, Pinon-Hofbauer, JD, Greil, R, Hartmann, TN ONKOLOGIE. 2010, 33: 201-202.